Apoferritin Attenuates Experimental Allergic Encephalomyelitis in SJL Mice
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Ferritin has been shown to attenuate iron-catalyzed oxidative damage in several experimental conditions. Since oxidative damage has been implicated in the pathogenesis of multiple sclerosis (MS) and experimental allergic encephalomyelitis (EAE), an animal model of MS, we tested the hypothesis that ferritin would act to attenuate disease. The experimental design was to increase plasma ferritin levels during the active stage of EAE by giving systemic injections of apoferritin and then compare disease activity between these mice and EAE mice administered vehicle. Additional mice received systemic injections of iron, which induces ferritin synthesis, in order to test the effects of exogenous iron on the disease course. Although plasma levels of ferritin were found to be elevated in both apoferritin and iron-injected EAE mice, only apoferritin treatment resulted in a reduction in disease activity compared to EAE mice given vehicle. The suppressive effects of apoferritin administration suggest that the increase in endogenous ferritin levels that have been previously observed in the cerebrospinal fluid of chronic progressive MS patients with active disease might be functioning to limit the severity and spread of tissue damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metal-catalyzed oxidation of proteins. Physiological consequences
Stadtman, E. R., & Oliver, C. N. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52199-2 · Cited by 862 · cited 2×
“…formation of the highly toxic hydroxyl radical [Halliwell and Gutteridge, 1984; Gutteridge, 1992]; (2) it induces secondary initiation of lipid peroxidation [Borg and Schaich, 1988; Borg, 1993], and (3) it can cause site-specific oxidation of proteins [Stadtman, 1990; Stadtman and Oliver, 1991].”
BackgroundCellular distribution of transferrin, ferritin, and iron in normal and aged human brains
Connor, J. R., Menzies, S. L., Martin, S. M. S., & Mufson, E. J. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270421 · Cited by 472 · cited 2×
“Oligodendrocytes, a pathological target in MS, normally express high levels of ferritin and the ferritin receptor [Connor et al., 1990; 1994; Sanyal et al., 1996; Hulet et al., 1999; 2000], and the levels of ferritin can be further increased when oligodendrocytes are exposed to stress such as…”
BackgroundSecretion of Ferritin by Rat Hepatoma Cells and Its Regulation by Inflammatory Cytokines and Iron
Tran, T. N., Eubanks, S. K., Schaffer, K. J., Zhou, C. Y. J., & Linder, M. C. (1997) · Blood · doi:10.1182/blood.v90.12.4979 · Cited by 236
Biemond, P., Swaak, A. J. G., Beindorff, C. M., & Koster, J. F. (1986) · Biochemical Journal · doi:10.1042/bj2390169 · Cited by 179 · cited 1×
“…been less capable of binding endogenous iron, or further, it could have been a potential source for promoting free radical tissue damage since iron can be released from iron stores within ferritin during inflammatory conditions [Biemond et al., 1986; Bolann and Ulvik, 1987; Yoshida et al., 1995].”
BackgroundIsoforms of ferritin have a specific cellular distribution in the brain
Connor, J. R., Boeshore, K. L., Benkovic, S. A., & Menzies, S. L. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370405 · Cited by 179
Mehindate, K., Sahlas, D. J., Frankel, D., Mawal, Y., Liberman, A., Corcos, J., Dion, S., & Schipper, H. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00354.x · Cited by 129 · cited 1×
“Heme oxygenase 1 (HO-1) is elevated in EAE and MS tissues [Emerson and LeVine, 2000; Schluesener and Seid, 2000; Mehindate et al., 2001] and it functions to release iron from heme.”
BackgroundInhibition of autoimmune neuropathological process by treatment with an iron-chelating agent.
Bowern, N., Ramshaw, I. A., Clark, I. A., & Doherty, P. C. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.5.1532 · Cited by 119 · cited 6×
“Pharmacological studies have found that iron chelation attenuates EAE [Bowern et al., 1984; Pedchenko and LeVine, 1998] and possibly MS [Norstrand and Craelius, 1989; Lynch et al.”
InfluentialDesferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice
Pedchenko, T. V., & LeVine, S. M. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00256-7 · Cited by 78 · cited 4×
“Pharmacological studies have found that iron chelation attenuates EAE [Bowern et al., 1984; Pedchenko and LeVine, 1998] and possibly MS [Norstrand and Craelius, 1989; Lynch et al., 1996], although further stud- 178 Dev Neurosci 2002;24:177–183 LeVine/Maiti/Emerson/Pedchenko ies need to be performed…”
BackgroundInfluentialSelf-citation
Cited by
Chemistry and biology of ferritin
Plays, M., Müller, S., & Rodriguez, R. (2021) · Metallomics · doi:10.1093/mtomcs/mfab021 · Cited by 232
Hu, C., Nydes, M., Shanley, K. L., Morales Pantoja, I. E., Howard, T. A., & Bizzozero, O. A. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14604 · Cited by 200
Ferritin in autoimmune diseases
Zandman-Goddard, G., & Shoenfeld, Y. (2007) · Autoimmunity Reviews · doi:10.1016/j.autrev.2007.01.016 · Cited by 191
Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients
Sfagos, C., Makis, A. C., Chaidos, A., Hatzimichael, E. C., Dalamaga, A., Kosma, K., & Bourantas, K. L. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1171oa · Cited by 84
Iron chelation and multiple sclerosis
Weigel, K. J., Lynch, S. G., & LeVine, S. M. (2014) · ASN NEURO · doi:10.1042/an20130037 · Cited by 63
“Apoferritin can bind large amounts of iron and protect against oxidative injury (discussed in LeVine et al., 2002).”
BackgroundInfluentialSelf-citationSena, A., Pedrosa, R., Ferret-Sena, V, Cascais, M., Roque, R., Araújo, C., & Couderc, R. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508089687 · Cited by 12
Metadata
- Authors
- LeVine, S. M., Maiti, S., Emerson, M. R., & Pedchenko, T. V.
- Venue
- Developmental Neuroscience
- Publisher
- S. Karger AG
- Published
- 2002
- Volume
- 24
- Issue
- 2-3
- Pages
- 177-183
- ISSN
- 0378-5866 (ISSN-L)
- 1421-9859
- OpenAlex
- W1999708823
- Cited by
- 21
- References
- 8
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.